Skip to content
Study details
Enrolling now

CV CARE: CardioVascular Care in PC Patients

Dana-Farber Cancer Institute
NCT IDNCT06202820ClinicalTrials.gov data as of Apr 2026
Target enrollment

180

Study length

about 3 years

Ages

18+

Sex

Male only

Locations

2 sites in MA

About this study

This trial is testing a program to assess and manage reversible cardiovascular (CV) risk factors in men with prostate cancer starting androgen deprivation therapy (ADT). The goal is to integrate this program into Dana-Farber Cancer Institute clinics for all such participants. This program, called CV Care, involves behavioral interventions.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in CV Care Program

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low6%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Secondary: Proportion of Participants on Blood Pressure Medications in CV CARE, Proportion of Participants on Blood Pressure Medications in CV CARE 2, Proportion of Participants with Blood Pressure Below 130/85 (mmHg) in CV CARE, Proportion of Participants with Blood Pressure Below 130/85 (mmHg) in CV CARE 2

Body systems

Cardiology / Heart, Oncology